Glenmark Life Sciences Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
06 Mar 24 | Sell₹40,298,760,871 | Glenmark Pharmaceuticals Limited | Company | 67,389,944 | ₹597.99 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 8,800 | 0.00718% |
Institutions | 4,609,895 | 3.76% |
Public Companies | 9,609,571 | 7.84% |
General Public | 16,402,621 | 13.4% |
Private Companies | 91,896,285 | 75% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
91,896,285 | ₹76.1b | 0% | no data | |||
9,609,571 | ₹8.0b | -90.5% | no data | |||
1,750,000 | ₹1.4b | 0% | 0.99% | |||
1,019,415 | ₹844.0m | 0% | 0.04% | |||
922,881 | ₹764.1m | 245% | 0.68% | |||
221,670 | ₹183.5m | -6.29% | no data | |||
141,929 | ₹117.5m | 0% | no data | |||
120,718 | ₹99.9m | 0% | no data | |||
88,953 | ₹73.7m | 0% | no data | |||
77,364 | ₹64.1m | 24% | no data | |||
55,667 | ₹46.1m | 0% | no data | |||
49,603 | ₹41.1m | -51.2% | no data | |||
38,000 | ₹31.5m | 0% | no data | |||
32,290 | ₹26.7m | 0% | no data | |||
28,692 | ₹23.8m | 0% | no data | |||
18,452 | ₹15.3m | 38.6% | no data | |||
15,701 | ₹13.0m | 10.9% | no data | |||
9,710 | ₹8.0m | -2.9% | no data | |||
8,663 | ₹7.2m | 24.7% | no data | |||
7,800 | ₹6.5m | 0% | no data | |||
5,465 | ₹4.5m | 57.8% | no data | |||
3,513 | ₹2.9m | -98.7% | no data | |||
3,164 | ₹2.6m | 77.9% | no data | |||
1,000 | ₹831.9k | 0% | no data | |||
694 | ₹578.2k | 726% | 0.01% |